ArticleHaematologica2025

Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.

Christina Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.